|
ZNF585B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.49810189095956E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.66053886991358E-15 |
| Normal-vs-Stage2 |
3.38200000227218E-08 |
| Normal-vs-Stage3 |
1.61509694507345E-11 |
| Normal-vs-Stage4 |
5.37547784063008E-12 |
| Stage1-vs-Stage2 |
8.778200E-01 |
| Stage1-vs-Stage3 |
1.785160E-01 |
| Stage1-vs-Stage4 |
5.387900E-02 |
| Stage2-vs-Stage3 |
2.797000E-01 |
| Stage2-vs-Stage4 |
1.231770E-01 |
| Stage3-vs-Stage4 |
5.105000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.0400017492791E-11 |
| Normal-vs-AfricanAmerican |
8.42250000000488E-05 |
| Normal-vs-Asian |
4.12210043876371E-10 |
| Caucasian-vs-AfricanAmerican |
3.121600E-01 |
| Caucasian-vs-Asian |
7.696400E-01 |
| AfricanAmerican-vs-Asian |
2.239400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20470300402076E-11 |
| Normal-vs-Female |
1.14410036999857E-10 |
| Male-vs-Female |
1.825190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92900029283294E-10 |
| Normal-vs-Age(41-60Yrs) |
6.7390537594747E-14 |
| Normal-vs-Age(61-80Yrs) |
3.35109717752857E-11 |
| Normal-vs-Age(81-100Yrs) |
8.625300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.348000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.696400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.185000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.859000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.103800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.482800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.269800E-02 |
| Classical-VS-Follicular |
4.745400E-01 |
| Classical-VS-Other |
1.251450E-01 |
| Classical-VS-Normal |
1.03590003242005E-09 |
| Tall-VS-Follicular |
1.192400E-01 |
| Tall-VS-Other |
6.760800E-01 |
| Tall-VS-Normal |
1.31039623596507E-11 |
| Follicular-VS-Other |
3.579000E-01 |
| Follicular-VS-Normal |
9.45760025850007E-10 |
| Other-VS-Normal |
3.020300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.14830408807165E-11 |
| Normal-vs-N1 |
4.22509804920423E-11 |
| N0-vs-N1 |
3.191200E-01 |
|
|
